Business
Organigram Global Announces CEO Succession Plan
Beena Goldenberg, CEO to retire at the end of the Company’s fiscal year Board of D...
About this update from Organigram Global Inc.
[{"type":"text","content":"Organigram Global Announces CEO Succession Plan\n\n\n .bwlistdisc { list-style-type: disc }\n \n\n\n\n\n\n Beena Goldenberg, CEO to retire at the end of the Company’s fiscal year\n \n\n\n\n Board of Directors\n \n\n expresses confidence in the Company’s strategic direction and leadership team\n \n\n\n\n Comprehensive CEO selection process will be initiated to identify a successor\n \n\n\n\n\n\n Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada’s #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company’s current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company’s Board of Directors (the “Board”) to advance Organigram’s strategic objectives, including international expansion, and to ensure an effective transition.\n \n\n Since joining Organigram as CEO in September 2021, Ms. Goldenberg successfully led the organization’s growth and transformation from a cannabis company with $80M in net revenue to becoming the market share leader in Canada with over $250M in net revenue. Under her leadership, the Company completed an expansion of its facility in Moncton, New Brunswick, doubling cultivation capacity, as well as three strategic acquisitions that led to the Company’s #1 share positions in vapes, hash and pre-rolls in Canada. In addition, Ms. Goldenberg oversaw Organigram’s international expansion with export sales into Germany, UK and Australia. The latest acquisition of Collective Project, announced on April 1, 2025, signaled the first revenue recognized by Organigram from the U.S. market.\n \n\n This announcement follows the Company’s second quarter fiscal year 2025 results, which were issued on May 12, 2025, and highlight the progress that has been made in enhancing Organigram’s financial performance. This includes realizing a 74% increase in net revenue year-over-year and delivering improvement across key financial metrics.\n \n\n “After five incredible years in the cannabis industry, serving as CEO of Supreme Cannabis Company and Organigram Global, I have decided it is time to move on to my next...